PMID- 29414555 OWN - NLM STAT- MEDLINE DCOM- 20190321 LR - 20190321 IS - 1525-5069 (Electronic) IS - 1525-5050 (Linking) VI - 80 DP - 2018 Mar TI - Specificity of electroclinical features in the diagnosis of ring chromosome 20. PG - 215-220 LID - S1525-5050(17)30560-7 [pii] LID - 10.1016/j.yebeh.2017.12.001 [doi] AB - BACKGROUND: Ring chromosome 20 (R20) syndrome is a chromosomal disorder characterized mainly by drug-resistant frontal lobe seizures, recurrent nonconvulsive status epilepticus (NCSE), and typical EEG features. The aim of this study was to investigate if this triad is common and specific to all patients with R20. METHODS: In this cross-sectional study (from 2000 to 2011), we selected patients who fulfilled at least two out of three criteria: drug-resistant frontal lobe seizures, recurrent NCSE, and characteristic electroencephalography (EEG) features. In all patients, diagnosis was based on karyotype analysis of at least 100 metaphases. RESULTS: We identified 36 patients who met at least two of the selected criteria: six patients (16.7%) with R20 and 30 (83.3%) without R20 (non-R20). All patients with R20 met all three criteria. Eleven (36.7%) patients without R20, however, also displayed the full triad. In 19 patients without R20 (63.3%), one of the three clinical features was missing: frontal lobe seizures were not resistant to antiepileptic drugs (AED) in four (13.3%), recurrent NCSE was missing in six (20%), and nine (30%) patients did not have typical EEG features. Based on this data, specificity was 63.3%, positive predictive value was 35.3%, and sensitivity and negative predictive values were 100%. Additionally, a review of all publications describing the R20 phenotype revealed that 81.98% of patients with R20 display the full electroclinical triad. CONCLUSIONS: In our study, all patients with R20 displayed the three electroclinical characteristics. This is in line with previous reports (presenting high sensitivity and negative predictive value). However, these features can also be observed in other epilepsies and are not specific to R20. Our findings suggest that in the presence of the full triad of symptoms, karyotype analysis focused on chromosome 20 should be conducted. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Gago-Veiga, A B AU - Gago-Veiga AB AD - Epilepsy Unit, Department of Neurology, Hospital Universitario de La Princesa, Diego de Leon 62, 28006 Madrid, Spain. FAU - Toledano, R AU - Toledano R AD - Epilepsy Program, Department of Neurology, Hospital Ruber International, La Maso 38, 28034 Madrid, Spain. FAU - Garcia-Morales, I AU - Garcia-Morales I AD - Epilepsy Program, Department of Neurology, Hospital Ruber International, La Maso 38, 28034 Madrid, Spain. FAU - Perez-Jimenez, M A AU - Perez-Jimenez MA AD - Epilepsy Monitoring Unit, Clinical Neurophysiology Department, Nino Jesus Pediatric University Hospital, Menendez Pelayo 65, 28009 Madrid, Spain. FAU - Bernar, J AU - Bernar J AD - Department of Genetics, Hospital Ruber International, La Maso 38, 28034 Madrid, Spain. FAU - Gil-Nagel, A AU - Gil-Nagel A AD - Epilepsy Program, Department of Neurology, Hospital Ruber International, La Maso 38, 28034 Madrid, Spain. Electronic address: agnagel@ruberinternacional.es. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180203 PL - United States TA - Epilepsy Behav JT - Epilepsy & behavior : E&B JID - 100892858 RN - Ring Chromosome 20 Syndrome SB - IM MH - Adolescent MH - Adult MH - Child MH - Chromosome Disorders/*genetics/physiopathology MH - Chromosomes, Human, Pair 20/*genetics MH - Cross-Sectional Studies MH - Cytogenetics MH - *Electroencephalography MH - Epilepsy/diagnosis/genetics MH - Female MH - Frontal Lobe MH - Humans MH - Karyotyping MH - Male MH - Predictive Value of Tests MH - *Ring Chromosomes MH - Seizures/*diagnosis/genetics MH - Sensitivity and Specificity MH - Status Epilepticus/*diagnosis/genetics OTO - NOTNLM OT - Drug-resistant epilepsy OT - EEG OT - Frontal lobe seizures OT - Nonconvulsive status epilepticus OT - Ring chromosome 20 EDAT- 2018/02/08 06:00 MHDA- 2019/03/22 06:00 CRDT- 2018/02/08 06:00 PHST- 2017/07/11 00:00 [received] PHST- 2017/12/01 00:00 [revised] PHST- 2017/12/01 00:00 [accepted] PHST- 2018/02/08 06:00 [pubmed] PHST- 2019/03/22 06:00 [medline] PHST- 2018/02/08 06:00 [entrez] AID - S1525-5050(17)30560-7 [pii] AID - 10.1016/j.yebeh.2017.12.001 [doi] PST - ppublish SO - Epilepsy Behav. 2018 Mar;80:215-220. doi: 10.1016/j.yebeh.2017.12.001. Epub 2018 Feb 3.